08:00 , Feb 17, 2014 |  BC Week In Review  |  Company News

Biolojic, AstraZeneca deal

Biolojic partnered with AstraZeneca's MedImmune LLC biologics unit to discover antibodies against undisclosed targets selected by MedImmune. Biolojic will be responsible for discovering and optimizing antibodies, and MedImmune will be responsible for preclinical and clinical...